Presentation is loading. Please wait.

Presentation is loading. Please wait.

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?  Serenella Castelvecchio,

Published by Modified over 5 years ago

Similar presentations

Presentation on theme: "Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?  Serenella Castelvecchio,"— Presentation transcript:

1 Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?  Serenella Castelvecchio, MD, Lorenzo Menicanti, MD, Andrea Garatti, MD, PhD, Roberto Tramarin, MD, Marianna Volpe, MD, Alessandro Parolari, MD, PhD  The Annals of Thoracic Surgery  Volume 102, Issue 3, Pages (September 2016) DOI: /j.athoracsur Copyright © Terms and Conditions

2 Fig 1 Forest plots for the major outcomes in recent meta-analysis comparing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in diabetic patients: (A) all-cause mortality, (B) cerebrovascular accident, (C) myocardial infarction, (D) repeated revascularization, and (E) major adverse cardiovascular events (MACE). The solid squares indicate the mean difference, the dashed vertical line indicates no effect, and the horizontal lines represent the 95% confidence interval. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © Terms and Conditions

Download ppt "Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?  Serenella Castelvecchio,"

Similar presentations

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Peter K. Smith, MD, Robert M. Califf, MD, Robert H
Robert A. Guyton, MD  The Annals of Thoracic Surgery 

Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Pre-existing psychological depression confers increased risk of adverse cardiovascular outcomes following cardiac surgery: A systematic review and meta-analysis 

Pre-existing psychological depression confers increased risk of adverse cardiovascular outcomes following cardiac surgery: A systematic review and meta-analysis 
Manuel Caceres, MD, Darryl S. Weiman, MD, JD 

Manuel Caceres, MD, Darryl S. Weiman, MD, JD 
Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A
Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.

Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.
The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting  Danny Chu, MD, Faisal.

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting  Danny Chu, MD, Faisal.
Robert A. Guyton, MD  The Annals of Thoracic Surgery 

Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M
Elizabeth L. Nichols, MS, Jock N. McCullough, MD, Cathy S

Elizabeth L. Nichols, MS, Jock N. McCullough, MD, Cathy S
Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome  Michael J. Mack, MD, Adrian P. Banning,

Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome  Michael J. Mack, MD, Adrian P. Banning,
Fred H. Edwards, MD, David M. Shahian, MD, Maria V

Fred H. Edwards, MD, David M. Shahian, MD, Maria V
Metabolic Syndrome Affects Midterm Outcome After Coronary Artery Bypass Grafting  Emiliano Angeloni, MD, Giovanni Melina, PhD, Umberto Benedetto, PhD,

Metabolic Syndrome Affects Midterm Outcome After Coronary Artery Bypass Grafting  Emiliano Angeloni, MD, Giovanni Melina, PhD, Umberto Benedetto, PhD,
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery  Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery  Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Surgical Ventricular Restoration: Is There Any Difference in Outcome Between Anterior and Posterior Remodeling?  Andrea Garatti, MD, Serenella Castelvecchio,

Surgical Ventricular Restoration: Is There Any Difference in Outcome Between Anterior and Posterior Remodeling?  Andrea Garatti, MD, Serenella Castelvecchio,
J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Similar presentations

Ads by Google